Healthcare News Options
Novo CEO pressed by Senate to cut costs of being overweight, diabetic issues medications CEO Lars Fruergaard Jørgensen instructed lawmakers the business would look at new talks with insurers regarding the checklist costs of Wegovy and copyright whenever they pledge to keep the medicines on their own formularies.Elevance lowers direction on ‘unpa